VCCBH News


Plante Appointed Bloomfield Professor

September 16, 2020 by Jennifer Nachbur

Timothy Plante ’06 M.D.’10, M.H.S., assistant professor of medicine, has been appointed the Martin E. Bloomfield ’56 M.D.’60 and Judith S. Bloomfield ’59 Early Career Professor in Cardiovascular Research at the University of Vermont’s Larner College of Medicine.

Timothy Plante ’06 M.D.’10, M.H.S., UVM Assistant Professor of Medicine

Timothy Plante ’06 M.D.’10, M.H.S., assistant professor of medicine, has been appointed the Martin E. Bloomfield ’56 M.D.’60 and Judith S. Bloomfield ’59 Early Career Professor in Cardiovascular Research at the University of Vermont’s Larner College of Medicine.

The professorship was established in 2017 by Martin and Judith Bloomfield, whose goal was to help young investigators combine practice and research by providing more assistance, reducing teaching loads, and offering salary support early in their careers at the Cardiovascular Research Institute of Vermont (CVRI). Martin Bloomfield, who is celebrating his 60th medical reunion in 2020, still recalls the difficulty in finding the time and resources necessary to conduct the research that interested him as a young cardiologist.

“During fellowship I was interested in myocardial hypertrophy and the role of hormones, but having little space and time prevented me from achieving any results,” said Bloomfield. “And the difficulty in obtaining grant money as a young investigator has always been a problem.”

The Bloomfields are longtime supporters of the Larner College of Medicine. Martin is a dual-degree UVM undergraduate and medical alum, and his wife and fellow UVM undergraduate alum Judith is a retired psychologist. In 2017, they created a separate endowment to support visiting professorships for the CVRI, and Martin also serves as a member of the UVM Foundation Leadership Council. In establishing the Bloomfield Professorship—the first of its kind at UVM—they hoped their philanthropy could change the course of careers in a way they had witnessed first-hand in their own family. Their son Dan, who followed in his father’s footsteps as a research cardiologist, also struggled early in his career to find windows of opportunity for his research. After earning an endowed assistant professorship, which relieved him of many of his teaching responsibilities, his projects flourished. He became a Doris Duke Fellow, and grant money followed. Today, the Bloomfield Professorship, inspired by their son’s experience, is helping to grow the reputation of the CVRI and paving the way for groundbreaking research by a new generation of investigators.

Benedek Erdos, M.D., Ph.D., assistant professor of pharmacology, was invested as the inaugural Bloomfield Early Career Professor in Cardiovascular Research in 2017. The endowment supported his research on “Brain-Derived Neurotrophic Factor, a Novel Hypothalamic Mediator in Hypertension,” an investigation of how the brain controls cardiovascular responses during stress.

“I am truly grateful for Dr. Bloomfield’s support, which gave us the opportunity to explore exciting new avenues in our research and promoted my scientific career in this critical phase of establishing an independent program,” said Erdos. “We were able to establish a novel animal model that allows us to study the activity of certain neurons that drive blood pressure higher during stress. This new model will help us unravel further details of the role this signaling mechanism plays in cardiovascular stress responses and in promoting augmented blood pressure responses to stress when multiple cardiovascular risk factors, such as high calorie or high salt diets, are combined. Our ultimate goal is to find novel therapeutic targets for the treatment of hypertension.”

Dr. Plante, a native Vermonter who incidentally earned his undergraduate and medical degrees from UVM exactly 50 years after Dr. Bloomfield, is a general internist practicing inpatient hospitalist medicine and outpatient thrombosis medicine at the UVM Medical Center. He conducts epidemiology research in the Laboratory for Clinical Biochemistry Research and is a member of the CVRI Early Career Advisory Committee. He completed an internal medicine residency at Georgetown University Hospital and a T32-sponsored fellowship in general internal medicine at Johns Hopkins School of Medicine, where he also earned a Master of Health Science degree in clinical epidemiology from the Bloomberg School of Public Health.

Plante’s project, titled “The Inflammatory Basis of Hypertension,” aims to identify phenotype patterns of inflammation using modern biostatistical techniques and assess their association with hypertension in the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study. In his proposal, Plante said that “This is an innovative, critical step required before assessing targeted inflammation lowering for primary prevention of inflammation-based hypertension.” The REGARDS study has accumulated 3,343 incident hypertension cases among 30,239 black and white adults across the U.S.

“Dr. Plante’s research, at the intersection of cardiovascular epidemiology and mobile health, is both novel and important,” said Larner College of Medicine Dean Richard L. Page, M.D. "We are grateful for the Bloomfield’s generosity in endowing this Early Career Professorship and for the support it will provide for Dr. Plante’s investigation.”

"This professorship is very unique and provides critical funding for those of us trying to gain independence," said Plante. "I am humbled and honored to have been selected for the Bloomfield Early Career Professorship and feel so fortunate to have this support.”
__

Fundraising for the Larner College of Medicine is a major focus for the University of Vermont Foundation, a nonprofit corporation established to secure and manage private support for the benefit of the University of Vermont. During the University’s eight-year Move Mountains comprehensive fundraising campaign, which concluded last summer, donors like the Bloomfields helped raise more than $290 million to support the Academic Health Sciences (the Larner College of Medicine, the College of Nursing & Health Sciences, and the UVM Medical Center). Today, the University boasts 124 endowed chairs and professorships—64 of those are associated with the Larner College of Medicine. More information about the impact of donors and the work of the UVM Foundation can be found at www.uvmfoundation.org
.



Recent Stories and Publications Featuring VCCBH Members


Research on spider brain leads to groundbreaking Alzheimer’s discovery

Posted December 3, 2024

Neurodegeneration in spider brain leads Vermont neuroscientists to groundbreaking discovery in Alzheimer’s-affected human brains 
Vermont Business Magazine Researchers from Saint Michael’s College and the University of Vermont have made a groundbreaking new discovery that provides a better understanding of how Alzheimer’s disease develops in the human brain.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 23, 2024

In a recent paper published in Nature Communications titled “Endothelial Piezo1 Channel Mediates Mechano-Feedback Control of Brain Blood Flow,” Osama Harraz, Ph.D., Bloomfield Early Career Professor in Cardiovascular Research and assistant professor of pharmacology at the Robert Larner, M.D. College of Medicine, and his team of researchers from American and European institutions reveal that Piezo1, a lesser-understood protein, acts as a “brake” system, helping blood flow return to normal after neural activity.

The association of leptin and incident hypertension in the reasons for geographic and racial differences in stroke (REGARDS) cohort

Posted October 23, 2024

Leptin is an adipokine associated with obesity and with hypertension in animal models. Whether leptin is associated with hypertension independent of obesity is unclear. Relative to White adults, Black adults have higher circulating leptin concentration.

Assessing prenatal and early childhood social and environmental determinants of health in the HEALthy Brain and Child Development Study (HBCD)

Posted October 23, 2024

The HEALthy Brain and Child Development (HBCD) Study, a multi-site prospective longitudinal cohort study, will examine human brain, cognitive, behavioral, social, and emotional development beginning prenatally and planned through early childhood.

Health Watch: UVM researchers unlock secrets of brain blood flow in cognitive health

Posted October 16, 2024

Osama Harraz, Ph.D and his team of researchers at the University of Vermont’s Larner College of Medicine have made a breakthrough that could help in the effort to better understand the causes of dementia and how to stop it.

UVM at the Forefront of Stroke and Brain Health Research

Posted October 14, 2024

REGARDS Study Grant Renewed: UVM’s Continued Contributions to Research on Stroke Disparities by Race and Geography. Investigators at the Larner College of Medicine are receiving a $10.1 million multi-year grant from the National Institutes of Health (NIH) to continue their 23-year program studying stroke and cognitive disorders in the United States.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted October 2, 2024

Investigators at the Larner College of Medicine have received a $10.1 million multi-year grant from the National Institutes of Health to continue their work on the REGARDS project. The purpose of the project is to understand why those in some U.S. regions develop more strokes and Alzheimer’s Disease and Related Dementia than others, and why Black people develop more strokes than white people.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted August 21, 2024

Mark Nelson, Ph.D., chair and University Distinguished Professor of pharmacology, gave the Björn Folkow Lecture at the 15th Mechanisms of Vasodilation/Endothelium-Dependent Hyperpolarization (MOVD/EDH) 2024 conference July 2–5 at Magdalen College in Oxford, United Kingdom.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 31, 2024

A collaborative research team co-led by investigators David Jangraw, Ph.D., M.S., and Denise Peters, Ph.D., D.P.T., PT, has been awarded the 2024 Armin Grams Memorial Research Award by the Center on Aging. 

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted July 10, 2024

Two Larner-affiliated researchers won their respective poster competitions at the Vermont Center for Cardiovascular and Brain Health symposium held June 6–7 at the University of Vermont’s Davis Center.

Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases

Posted May 15, 2024

John Salogiannis, Ph.D., assistant professor of molecular physiology and biophysics, and members of his lab team—Allison (Morrissey) Langley, lab technician and Ph.D. candidate in cellular, molecular, and biomedical sciences; Sarah Abeling-Wang, lab research technician; and Erinn Wagner, UVM undergraduate biology major—have their first preprint*: “Movement of the endoplasmic reticulum is driven by multiple classes of vesicles marked by Rab-GTPases.” The team’s research is supported by an NIH Maximizing Investigators’ Research Award (MIRA or R35) for early-stage investigators.

The University of Vermont Center on Aging Newsletter

Posted May 2024

Katharine Cheung, M.D., Ph.D., M.Sc., interim director of the UVM Center on Aging, associate director for research, and assistant professor of medicine, and her mentee, medical student Susanna Schuler ’26, presented their research findings at the American Academy of Hospice and Palliative Medicine State of the Science meeting on March 23 in Phoenix, Arizona.

Larner College of Medicine Dean's Newsletter, Accolades and Accomplishments

Posted March 6, 2024

A study by a nationwide collaborative group, including Larner scientists Mary Cushman, M.D., M.Sc., University of Vermont Distinguished Professor and co-director of the Vermont Center for Cardiovascular and Brain Health, Russell Tracy, Ph.D., University of Vermont Distinguished Professor and director of UVM’s Laboratory for Clinical Biochemistry Research, Margaret Doyle Ph.D., associate professor of Pathology and Laboratory Medicine and co-director of the Laboratory of Clinical Biochemistry, and Rebekah Boyle, M.S., was recently published in Nature Communications.

 

UVM Scientist Wins Chan Zuckerberg Initiative Grant to Tackle Neurodegenerative Diseases

Larner Scientist Seeks to Advance Neurodegeneration Research

February 22, 2024

Larner College of Medicine scientist Osama Harraz, Ph.D., M.Sc., and his colleague from the University of Maryland (UMD), Thomas Longden, Ph.D., are recipients of a prestigious Collaborative Pairs Pilot Project Award from the Chan Zuckerberg Initiative’s (CZI) Neurodegeneration Challenge Network (NCDN).